BioCentury
ARTICLE | Company News

Axcan, Aventis GI product deal

October 9, 2003 7:00 AM UTC

Axcan (TSE:AXC; AXCA) acquired North American rights from AVE to duodenal ulcer drug Carafate (Sulcrate in Canada), irritable bowel syndrome drug Bentyl (Bentylol in Canada) and hemorrhoidal drug Proc...